摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

11-Hydroxy-trans-undec-2-en-saeure | 55027-39-9

中文名称
——
中文别名
——
英文名称
11-Hydroxy-trans-undec-2-en-saeure
英文别名
11-Hydroxy-undecen-(2t)-saeure-(1);11-hydroxy-undeca-2t-enoic acid;11-Hydroxy-2-undecenoic acid;(E)-11-hydroxyundec-2-enoic acid
11-Hydroxy-trans-undec-2-en-saeure化学式
CAS
55027-39-9
化学式
C11H20O3
mdl
——
分子量
200.278
InChiKey
UHMWYQAZYGDJGM-VQHVLOKHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    367.5±15.0 °C(Predicted)
  • 密度:
    1.022±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    14
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Novel Unsaturated Fatty Hydroxy Acid Derivatives and the Dermocosmetologic Use Thereof
    申请人:Charveron Marie
    公开号:US20090238784A1
    公开(公告)日:2009-09-24
    The invention relates to unsaturated fatty hydroxy acid derivatives of formula (I), wherein R n is independent from each other H or linear or branched alkyl group which contain from 1 to 6 carbon atoms and which are possibly substituted by a halogen atom, in particular a fluorine atom, R 1 is H, F, Cl, Br or CF 3 , R is H or linear or branched alkyl group which contain from 1 to 6 carbon atoms and which are possibly substituted by a halogen atom, in particular a fluorine atom and 3=n=14. Said derivatives is suitable for producing an anti-radical, anti-inflammatory and antipruritic dermocosmetologic composition and/or for treating keratinisation and pigmentation troubles and/or for improving healing.
    该发明涉及公式(I)的不饱和脂肪羟基酸衍生物,其中Rn是H或线性或支链烷基基团,含有1至6个碳原子,并且可能被卤素原子(特别是氟原子)取代,R1是H、F、Cl、Br或CF3,R是H或线性或支链烷基基团,含有1至6个碳原子,并且可能被卤素原子(特别是氟原子)取代,3=n=14。所述衍生物适用于生产抗自由基、抗炎和抗瘙痒的皮肤化妆品组合物和/或治疗角化和色素沉着问题和/或改善愈合。
  • BESIFLOXACIN FOR THE TREATMENT OF RESISTANT ACNE
    申请人:Vyome Therapeutics Limited
    公开号:EP3698793A1
    公开(公告)日:2020-08-26
    The present disclosure relates to formulations comprising besifloxacin for use in the treatment of acne and more specifically resistant acne.
    本公开涉及包含贝西沙星的制剂,用于治疗痤疮,更具体地说是抗药性痤疮。
  • Treatments for resistant acne
    申请人:VYOME BIOSCIENCES PVT. LTD.
    公开号:US10071103B2
    公开(公告)日:2018-09-11
    The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.
    本公开内容一般涉及用于治疗细菌感染的新型分子、组合物和制剂,更具体地说,涉及具有抗生素耐药性病原体的细菌感染。
  • Syntheses of 9-Keto- and 10-Hydroxy-trans-2-decenoic Acids and Related Compounds
    作者:Keiiti Sisido、Mituyosi Kawanisi、Kiyosi Kondô、Teizirô Morimoto、Akihisa Saitô、Norihiko Hukue
    DOI:10.1021/jo01058a518
    日期:1962.11
  • TREATMENTS FOR RESISTANT ACNE
    申请人:VYOME BIOSCIENCES PVT. LTD.
    公开号:US20160346294A1
    公开(公告)日:2016-12-01
    The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens
查看更多